MedPath

金诺康药业科技(石家庄)有限公司

Ownership
-
Established
2021-07-27
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:3

Drug Approvals

Macrogol 4000 Powder

Product Name
聚乙二醇4000散
Approval Number
国药准字H20253591
Approval Date
Mar 11, 2025
NMPA

Carbocisteine Granules

Product Name
羧甲司坦颗粒
Approval Number
国药准字H20093719
Approval Date
Feb 1, 2024
NMPA

Tobramycin Sulfate Injection

Product Name
硫酸妥布霉素注射液
Approval Number
国药准字H44023571
Approval Date
Nov 15, 2022
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath